A novel HER2-targeting antibody 5G9 identified by large-scale trastuzumab-based screening exhibits potent synergistic antitumor activity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A novel HER2-targeting antibody 5G9 identified by large-scale trastuzumab-based screening exhibits potent synergistic antitumor activity

Published:2020-10 Issue: Volume:60 Page:102996
ISSN:2352-3964
Container-title:EBioMedicine
language:en
Short-container-title:EBioMedicine

Author:

Ding Xiaoyu,Gu Wanjian,Zhong Yujie,Hao Xiaoyao,Liu Jinyu,Xia Shukai,Luo Lan,Chen Mingjiu,Zhang Chunni

Funder

National Natural Science Foundation of China

State Key Laboratory of Analytical Chemistry for Life Science

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference39 articles.

1. Characterization of the epidermal growth factor receptor and the erbB oncogene product by site-specific antibodies;Akiyama;Arch Biochem Biophys,1986

2. The basic biology of HER2;Rubin;Ann Oncol,2001

3. Biology of HER2 and its importance in breast cancer;Yarden;Oncology,2001

4. HER2 as a target for breast cancer therapy;Tagliabue;Expert Opin Biol Ther,2010

5. ErbB/HER protein-tyrosine kinases: structures and small molecule inhibitors;Roskoski;Pharmacol Res,2014

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting HER2 in solid tumors: Unveiling the structure and novel epitopes;Cancer Treatment Reviews;2024-11

2. Therapeutic potential of cis-targeting bispecific antibodies;Cell Chemical Biology;2024-08

3. Multiparatopic antibodies induce targeted downregulation of programmed death-ligand 1;Cell Chemical Biology;2024-05

4. Impact of synthesis methods on the functionality of antibody-conjugated gold nanoparticles for targeted therapy;Nanoscale Advances;2024

5. A novel nanobody-based HER2-targeting antibody exhibits potent synergistic antitumor efficacy in trastuzumab-resistant cancer cells;Frontiers in Immunology;2023-10-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3